Our Book of Scouting Reports offers in-depth analysis on AI companies in preclinical development — the phase before clinical trials that involves testing drug candidates through in vitro, in vivo, and in silico studies to establish safety and efficacy.
Combining CB Insights’ proprietary data and AI, scouting reports provide insight into each company’s:
- Funding history
- Headcount
- Key takeaways (including opportunities and threats)
- Product/tech focus
- Mosaic score
For customers, get the full book of 30+ scouting reports using the download button on the lefthand side.
MORE CB INSIGHTS RESEARCH ON AI IN DRUG R&D:
- AI’s moment in preclinical drug development arrives: Why formulation tech is the next frontier
- The AI in drug R&D market map
- Book of Scouting Reports: AI Drug Discovery
For information on reprint rights or other inquiries, please contact reprints@cbinsights.com.
